Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Division of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikwa, Israel.
United European Gastroenterol J. 2021 Apr;9(3):307-331. doi: 10.1002/ueg2.12061.
BACKGROUND: Functional dyspepsia (FD) is one of the most common conditions in clinical practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its definition, underlying pathophysiology, diagnosis, treatment, and prognosis. METHODS: A Delphi consensus was initiated with 41 experts from 22 European countries who conducted a literature summary and voting process on 87 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation (GRADE) criteria. Consensus (defined as >80% agreement) was reached for 36 statements. RESULTS: The panel agreed with the definition in terms of its cardinal symptoms (early satiation, postprandial fullness, epigastric pain, and epigastric burning), its subdivision into epigastric pain syndrome and postprandial distress syndrome, and the presence of accessory symptoms (upper abdominal bloating, nausea, belching), and overlapping conditions. Also, well accepted are the female predominance of FD, its impact on quality of life and health costs, and acute gastrointestinal infections, and anxiety as risk factors. In terms of pathophysiological mechanisms, the consensus supports a role for impaired gastric accommodation, delayed gastric emptying, hypersensitivity to gastric distention, Helicobacter pylori infection, and altered central processing of signals from the gastroduodenal region. There is consensus that endoscopy is mandatory for establishing a firm diagnosis of FD, but that in primary care, patients without alarm symptoms or risk factors can be managed without endoscopy. There is consensus that H. pylori status should be determined in every patient with dyspeptic symptoms and H. pylori positive patients should receive eradication therapy. Also, proton pump inhibitor therapy is considered an effective therapy for FD, but no other treatment approach reached a consensus. The long-term prognosis and life expectancy are favorable. CONCLUSIONS AND INFERENCES: A multinational group of European experts summarized the current state of consensus on the definition, diagnosis and management of FD.
背景:功能性消化不良(FD)是临床实践中最常见的病症之一。尽管其发病率很高,但 FD 在定义、潜在病理生理学、诊断、治疗和预后方面仍存在重大不确定性。
方法:来自 22 个欧洲国家的 41 名专家启动了一项 Delphi 共识,对 87 项声明进行了文献总结和投票。使用推荐评估、制定和评估(GRADE)标准评估证据质量。达成了 36 项声明的共识(定义为>80%的一致性)。
结果:专家组同意其主要症状(早饱、餐后饱胀、上腹痛和上腹痛灼热感)的定义,其分为上腹痛综合征和餐后不适综合征,以及附加症状(上腹部饱胀、恶心、打嗝)和重叠病症。FD 也被认为是女性患病率较高、对生活质量和医疗费用的影响以及急性胃肠感染和焦虑是危险因素。在病理生理机制方面,共识支持胃容纳功能受损、胃排空延迟、对胃扩张的高敏感性、幽门螺杆菌感染以及胃十二指肠区域信号的中枢处理改变的作用。专家组一致认为,内镜检查对于明确 FD 的诊断是强制性的,但在初级保健中,没有报警症状或危险因素的患者可以在不进行内镜检查的情况下进行管理。专家组一致认为,应在每个有消化不良症状的患者中确定幽门螺杆菌状态,阳性患者应接受根除治疗。质子泵抑制剂治疗也被认为是 FD 的有效治疗方法,但没有其他治疗方法达成共识。长期预后和预期寿命良好。
结论和推断:一组来自欧洲的多国专家总结了当前对 FD 的定义、诊断和管理的共识状态。
United European Gastroenterol J. 2021-4
United European Gastroenterol J. 2021-4
World J Gastroenterol. 2016-5-14
Am J Gastroenterol. 2017-1
J Clin Gastroenterol. 2012-3
World J Gastroenterol. 2011-7-21
Keio J Med. 2021-3-25
Cochrane Database Syst Rev. 2025-5-8
Front Med (Lausanne). 2025-2-25
Neurogastroenterol Motil. 2025-7
United European Gastroenterol J. 2025-4
Clin Gastroenterol Hepatol. 2021-8
Am J Gastroenterol. 2020-8
Front Psychiatry. 2020-3-18
Expert Opin Ther Targets. 2020-6
Evid Based Complement Alternat Med. 2019-11-14
Clin Gastroenterol Hepatol. 2020-4
Aliment Pharmacol Ther. 2019-3-28
Expert Rev Gastroenterol Hepatol. 2018-11-8